Video Library

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Video Library

Lung Cancer Doctor Videos

Dr. Renato Martins

Dr. Renato Martins

Dr. Renato Martins is the medical director for thoracic/head and neck oncology as well as outpatient general oncology and hematology at SCCA. In this video, Dr. Martins discusses making cancer a more manageable chronic disease. The best chance to cure someone is with the initial treatment. Once the disease has returned, a cure is less likely. Where a patient gets their initial treatment is key to their ultimate outcome. Patients that may be considered inoperable elsewhere, maybe considered operable here at SCCA. SCCA's experience and research is resulting in therapies and treatments that are available today at SCCA and that will only be available at other centers in the future. These advances make our objective of turning cancer into a chronic disease so that patients can be treated and still enjoy a high quality of life.
Dr. Michael Mulligan

Dr. Michael Mulligan

Dr. Michael Mulligan is the Director of Minimally Invasive Thoracic Surgery and regularly performs and teaches video-assisted thoracic surgery (VATS). In this video, he describes what differentiates SCCA from other institutions. The UW has the only lung transplant program in the area and does more complex airway surgeries than anywhere in the United States. We have tremendous lung cancer oncology at an institution with three Nobel Prize laureates. We now have a variety of minimally invasive surgical techniques, including video assisted and robotic thoracic surgery that are changing the way we do lung cancer surgery.
Dr. Douglas Wood

Dr. Douglas Wood

Dr. Douglas Wood is a UW professor and chief of the Division of Cardiothoracic Surgery. In this video he explains why getting treated at a cancer center such as SCCA is so important to outcomes. In many parts of the country, at least half of the patients with lung cancer are operated on surgeons that are not thoracic surgeons. We have found a consistent pattern of improved outcomes in patients that have their lung cancer surgery by thoracic surgeons. There is clear evidence, particularly in lung and esophageal cancer, that hospitals and centers that take care of more patients with these specific cancers have better outcomes both short term and long term.
Dr. Shilpen Patel

Dr. Shilpen Patel

Dr. Patel is a radiation oncologist who specializes in the treatment of thoracic cancer, including lung, thymic, and tracheal tumors, gastrointestinal cancers, and chest sarcoma at UW Medical Center and SCCA Proton Therapy. In this video Dr. Patel describes SCCA's approach to treating patients. At SCCA we strive to treat each patient as a member of our family. We pride ourselves in establishing and maintaining long-term relationships with our patients. Because patients who are highly informed have better results, we seek to educate our patients on all the options available. We use a team of physicians, along with the patient; to develop the best individualized therapy available. Our experts specialize in specific tumors and have experience and vast knowledge of years of treatment and know how to help patients succeed.
Dr. Farhood Farjah

Dr. Farhood Farjah

Thoracic surgeon, Dr. Farhood Farjah, is inspired by his patients. He and his colleagues at Seattle Cancer Care Alliance take the time to get to know the people they work with and discuss how the treatment will impact their daily lives. Dr. Farjah's is board certified for general surgery, but his clinical focus is entirely on thoracic treatment. He specializes in minimally invasive surgery, which uses a series of small incisions rather than one large one. As a result, recovery time is reduced, patients get out of the hospital faster and experience less pain.

Lung Cancer Screening Videos

Dr. Renato Martins

Dr. Renato Martins

Lung cancer is a leading cause of death among American men and women, but thankfully today we have more treatment options. Dr. Renato Martins tells of a large national trial showing that CT scans that detect small lesions in the lungs before patients become symptomatic can lowering mortality rates by 20%. The standard of care is now to offer screening to patients with a significant past history of smoking. Specific lung cancers have been identified that can behave differently from another, and at SCCA we are now testing 194 different genetic abnormalities that can happen in lung cancer. And for many of those abnormalities we don't have a therapy yet, but for some we do.
Dr. David Madtes (long)

Dr. David Madtes (long)

Dr. David Madtes discusses causes, detection, and survival rates of lung cancer. Lung cancer is the leading cause of cancer death in American men and women, responsible for more deaths than breast, pancreatic, prostate and colorectal cancers combined. Ninety percent of lung cancers occur in current or former smokers. Seventy-five percent of lung cancers are detected at advanced stages after growing silently for months or even years before symptoms manifest. By then the cancer has usually spread to other parts of the chest or organs, making treatment difficult and cure almost impossible. Five year survival rates of Stage I lung cancer are 70%, advanced stage is only 5%. This is why screening and early detection is so important. A recent national lung screening trial showed that low-dose CT screening of high risk individuals reduced lung cancer deaths by 20% compared to those who only had chest X-rays.
Dr. David Madtes (short)

Dr. David Madtes (short)

Dr. Madtes talks about low-dose CT scans and the benefits of detecting lung cancer early on.

Lung Cancer Surgery Videos

Minimally Invasive Surgery for Lung Cancer Treatment

Minimally Invasive Surgery for Lung Cancer Treatment

Dr. Michael Mulligan talks about the benefits of minimally invasive surgery for lung cancer. In recent years there have been improvements in both early detection of lung cancer, as well as surgical techniques for treatment. Traditionally, lung cancer was treated with a thoracotomy, or large incision in the chest where muscles may be divided and ribs removed or spread. New techniques have evolved that allow surgeons to make one-inch or smaller incisions and use high definition cameras and custom design instrumentation to perform the same operation. Patients recover more quickly, have less pain, and tolerate additional therapy, such as chemotherapy or radiation, much better that patients who undergo open surgery.
Thoracic Surgery for Lung Cancer Treatment

Thoracic Surgery for Lung Cancer Treatment

Dr. Farhood Farjah describes the different types of thoracic surgery techniques for lung cancer treatment. 

Lung Cancer Survival Rate Videos

Dr. Michael Mulligan on Survival Rates (long)

Dr. Michael Mulligan on Survival Rates (long)

Today, there is hope for people fighting lung cancer. Dr. Michael Mulligan explains why Seattle Cancer Care Alliance survivor rates are statistically higher than the national average. SCCA has shifted the way they approach treatment, both medically and surgically. While there were only a few options for chemotherapy in the past, today they are designing individualized treatment regimens. SCCA are also using minimally invasive surgical techniques that significantly reduces the time it takes for a patient to recover from surgery.
Dr. Michael Mulligan on Survival Rates (short)

Dr. Michael Mulligan on Survival Rates (short)

Dr. Michael Mulligan explains why lung cancer survival rates at Seattle Cancer Care Alliance are so good. He describes a broad based, innovative team that has advanced major changes in medical oncology and surgery. They are now able to design a individualized regimen for each patient and use minimally invasive surgical techniques to significantly reduce recovery time.